Literature DB >> 32651965

Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.

Sina M Matalqah1,2, Khalid Aiedeh1, Nizar M Mhaidat3, Karem H Alzoubi3, Yasser Bustanji4,5, Islam Hamad6.   

Abstract

Natural polymers, particularly polysaccharide, have been used as drug delivery systems for a variety of therapeutic agents such as peptides, proteins, vaccines, DNA, and drugs for parenteral and non-parenteral administration. Chitosan, the second most abundant naturally occurring polysaccharide after cellulose, is a biocompatible and biodegradable mucoadhesive polymer that is extensively used in the preparation of nanoparticles (NPs). Chitosan NPs loaded with drugs were found to be stable, permeable and bioactive. In this review, the importance of chitosan and its derivatives in drug delivery is illustrated, different methods of preparation of chitosan and chitosan derivatives NPs and their physio- chemical properties are addressed. Moreover, the desirable characteristics of successful NPs based drug delivery systems, as well as the pharmaceutical applications of these NPs are also clearly explored. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Chitosan; desolvation; drug delivery; emulsification; ionic gelation; nanoparticles

Year:  2020        PMID: 32651965     DOI: 10.2174/1389450121666200711172536

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  4 in total

Review 1.  Polysaccharide-Based Transdermal Drug Delivery.

Authors:  Jingyuan Li; Hong Xiang; Qian Zhang; Xiaoqing Miao
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-14

2.  Production of α-Tocopherol-Chitosan Nanoparticles by Membrane Emulsification.

Authors:  Sonia Trombino; Teresa Poerio; Federica Curcio; Emma Piacentini; Roberta Cassano
Journal:  Molecules       Date:  2022-04-03       Impact factor: 4.411

Review 3.  Nanostructured Antibiotics and Their Emerging Medicinal Applications: An Overview of Nanoantibiotics.

Authors:  Shreya Modi; Gajendra Kumar Inwati; Amel Gacem; Shahabe Saquib Abullais; Rajendra Prajapati; Virendra Kumar Yadav; Rabbani Syed; Mohammed S Alqahtani; Krishna Kumar Yadav; Saiful Islam; Yongtae Ahn; Byong-Hun Jeon
Journal:  Antibiotics (Basel)       Date:  2022-05-25

Review 4.  Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19.

Authors:  Jialu Huang; Yubo Ding; Jingwei Yao; Minghui Zhang; Yu Zhang; Zhuoyi Xie; Jianhong Zuo
Journal:  Vaccines (Basel)       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.